全文获取类型
收费全文 | 3187篇 |
免费 | 119篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 129篇 |
儿科学 | 43篇 |
妇产科学 | 73篇 |
基础医学 | 424篇 |
口腔科学 | 32篇 |
临床医学 | 246篇 |
内科学 | 1070篇 |
皮肤病学 | 12篇 |
神经病学 | 223篇 |
特种医学 | 73篇 |
外科学 | 399篇 |
综合类 | 26篇 |
预防医学 | 131篇 |
眼科学 | 38篇 |
药学 | 243篇 |
中国医学 | 3篇 |
肿瘤学 | 151篇 |
出版年
2024年 | 3篇 |
2023年 | 34篇 |
2022年 | 197篇 |
2021年 | 303篇 |
2020年 | 63篇 |
2019年 | 88篇 |
2018年 | 121篇 |
2017年 | 68篇 |
2016年 | 92篇 |
2015年 | 103篇 |
2014年 | 114篇 |
2013年 | 168篇 |
2012年 | 230篇 |
2011年 | 239篇 |
2010年 | 119篇 |
2009年 | 86篇 |
2008年 | 180篇 |
2007年 | 210篇 |
2006年 | 216篇 |
2005年 | 182篇 |
2004年 | 172篇 |
2003年 | 154篇 |
2002年 | 113篇 |
2001年 | 12篇 |
2000年 | 6篇 |
1999年 | 5篇 |
1998年 | 9篇 |
1997年 | 5篇 |
1996年 | 2篇 |
1994年 | 4篇 |
1993年 | 1篇 |
1990年 | 2篇 |
1987年 | 1篇 |
1986年 | 1篇 |
1985年 | 2篇 |
1984年 | 2篇 |
1980年 | 1篇 |
1979年 | 2篇 |
1978年 | 1篇 |
1976年 | 2篇 |
1975年 | 1篇 |
1973年 | 1篇 |
1972年 | 1篇 |
排序方式: 共有3316条查询结果,搜索用时 15 毫秒
61.
62.
63.
64.
Milchert M Fischer K Flicinski J Przepiera-Bedzak H Brzosko M 《The Journal of rheumatology》2012,39(9):1898-9; author reply 1899
65.
Jacek A. ?migielski ?ukasz Piskorz Marcin Wawrzycki Przemys?aw Dobielski Ma?gorzata Pikala S?awomir Jab?oński Marian Brocki 《Archives of Medical Science》2013,9(4):677-683
Introduction
We would save many lives and spare a lot of suffering if we could only detect and accurately determine the character and TMN staging of pancreatic tumors (PTs). With improved diagnosis, we could offer specific treatment that would result in better treatment outcome. The aim of study was to determine the significance of neoplastic markers CA 19-9 and CEA for prognosis in inflammatory and carcinomatous PTs.Material and methods
We based our research upon a group of 170 patients. The patients were treated in our Oncologic Surgery Department from January 2007 to December 2010 for PTs. The patients were divided into four groups depending on the character of the tumor and underwent the following treatments: group 1 – 34 patients with carcinoma of the ampulla of Vater, group 2 – 64 patients with PTs at different stages (1, 2, 3) according to TMN classification, group 3 – 62 patients with PTs at stage 4 on the TMN scale (unresectable tumors), group 4 – 28 patients with inflammatory PTs.Results
The results of Ca 19-9 in group 2 were 736.00 (25–75% 220.40–4285.00) ng/ml before surgery, 53.00 (25–75% 12.60–84.00) ng/ml in the 7 days after surgery, 29.4 (25–75% 7.90–113.00) ng/ml at day 30, and 119.00 (25–75% 96.30–621.00) ng/ml 3 months after the operation. These results were significantly higher than the control group but were significantly lower than the results for group 3 (unresectable tumors). The highest average concentration and median for CA 19-9 and CEA were noted in patients with unresectable PTs (the 3rd group). The average concentration for CEA was lowest in group 4, but much higher than the lab limits.Conclusions
The sensitivity of the CA 19-9 marker may be as high as 88%. Values of CA 19-9 above 852 U/ml may indicate TNM stage 4, consistent with an unresectable PT. In the cases where CA 19-9 is within normal limits but C-reactive protein is above normal limits (often thirty times the upper limit), in comparison to the control group and to patients with pancreatic neoplasms, strong consideration should be given towards the inflammatory characteristics of the pancreatic changes and conservative treatment should be applied. 相似文献66.
Barbara Chmielewska Krystyna Lis Konrad Rejdak Marcin Balcerzak Barbara Steinborn 《Archives of Medical Science》2013,9(5):858-864
Introduction
The Adverse Event Scale in Patients With Epilepsy (aESCAPE) European study () explored and analyzed adverse events (AEs) and reasons for modifying treatment in patients treated with newer and older antiepileptic drugs (AEDs) used in monotherapy or polytherapy. The present analysis concerns the results of patients recruited in Poland. NCT00394927Material and methods
Multicentre, international, observational, cross-sectional study investigating AEs in patients with epilepsy (aged ≥ 4 years), on stable AED treatment with one or two AED(s) for ≥ 3 months, using standardized questionnaires completed by a physician during a single study visit.Results
Out of 309 patients, 24.6% were treated exclusively with newer AED(s) in monotherapy or in combination, while 75.4% were treated with older AED(s) or a combination of older and newer AED(s). 60.8% were on monotherapy, and 39.9% on polytherapy. In general, 73.8% of patients reported ≥ 1 AE(s). There were no significant differences in the frequency of reported AEs in compared groups. The most common were disturbances in cognitive function (40.5%), psychological problems (36.2%), and sedation (32.7%). Some AEs were found to be more specific for particular types and treatment regimens. Changes in treatment or dose during the study visit occurred in 22.3% of the patients, mainly due to lack of efficacy (10.7%), AEs (5.2%) or absence of seizures (4.5%).Conclusions
A detailed structured interview revealed high frequency of AEs in patients treated with AEDs. The main reasons for treatment modifications at the study visit were lack of efficacy, adverse events and absence of seizures. 相似文献67.
68.
We compared the effect of subcutaneous adalimumab injections with intraarticular glucocorticoid injections on frozen shoulder of 18 patients with unilateral joint involvement. Ten patients were randomised to subcutaneous injections with adalimumab and eight to intraarticular glucocorticoid injections administered every other week for a total of three administrations. The evaluation included validated scores. No effect of subcutaneous injections of adalimumab on frozen shoulder symptoms was demonstrated. 相似文献
69.
70.